NZ232278A - N-(aryl-, thienyl- or furanyl-substituted alkyl) pyrrole-2-carboxylic acid derivatives and medicaments - Google Patents
N-(aryl-, thienyl- or furanyl-substituted alkyl) pyrrole-2-carboxylic acid derivatives and medicamentsInfo
- Publication number
- NZ232278A NZ232278A NZ232278A NZ23227890A NZ232278A NZ 232278 A NZ232278 A NZ 232278A NZ 232278 A NZ232278 A NZ 232278A NZ 23227890 A NZ23227890 A NZ 23227890A NZ 232278 A NZ232278 A NZ 232278A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compound
- formula
- pyrrole
- unsubstituted
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30414189A | 1989-01-31 | 1989-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ232278A true NZ232278A (en) | 1992-07-28 |
Family
ID=23175237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ232278A NZ232278A (en) | 1989-01-31 | 1990-01-29 | N-(aryl-, thienyl- or furanyl-substituted alkyl) pyrrole-2-carboxylic acid derivatives and medicaments |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0381141B1 (no) |
| JP (1) | JP2841305B2 (no) |
| KR (1) | KR0139288B1 (no) |
| CN (1) | CN1022754C (no) |
| AR (1) | AR245694A1 (no) |
| AT (1) | ATE135702T1 (no) |
| AU (1) | AU629290B2 (no) |
| CA (1) | CA2008616C (no) |
| DE (1) | DE69025967T2 (no) |
| ES (1) | ES2087093T3 (no) |
| FI (1) | FI900464A7 (no) |
| HU (1) | HU209290B (no) |
| IL (1) | IL93187A (no) |
| NO (1) | NO174887C (no) |
| NZ (1) | NZ232278A (no) |
| PT (1) | PT93009A (no) |
| ZA (1) | ZA90554B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
| AU625688B2 (en) * | 1989-01-31 | 1992-07-16 | Merrell Dow Pharmaceuticals Inc. | Method of using aryl- or heteroaryl-1-alkyl-pyrrole-2- carboxylic acid compounds in the treatment of interleukin-1 mediated conditions |
| BR112012000606A2 (pt) * | 2009-07-10 | 2016-11-22 | Brigham & Womens Hospital | análogos de etomidato que não inibem a síntese de esteróides adrenocorticais |
| CN102114430B (zh) * | 2009-12-30 | 2013-06-05 | 上海睿智化学研究有限公司 | 催化剂、其制备方法及n-烷基吡咯衍生物的制备方法 |
| IN2014DN06132A (no) | 2012-01-13 | 2015-08-14 | Gen Hospital Corp |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4112112A (en) * | 1976-06-29 | 1978-09-05 | Merck & Co., Inc. | Pyrrolo[2,1-b] [3]benzazepines useful for producing a skeletal muscle relaxing or tranquilizing effect |
-
1990
- 1990-01-25 AU AU48759/90A patent/AU629290B2/en not_active Ceased
- 1990-01-25 ZA ZA90554A patent/ZA90554B/xx unknown
- 1990-01-25 AR AR90316008A patent/AR245694A1/es active
- 1990-01-25 CA CA002008616A patent/CA2008616C/en not_active Expired - Fee Related
- 1990-01-26 IL IL9318790A patent/IL93187A/en not_active IP Right Cessation
- 1990-01-29 JP JP2016304A patent/JP2841305B2/ja not_active Expired - Fee Related
- 1990-01-29 NZ NZ232278A patent/NZ232278A/en unknown
- 1990-01-30 AT AT90101809T patent/ATE135702T1/de not_active IP Right Cessation
- 1990-01-30 EP EP90101809A patent/EP0381141B1/en not_active Expired - Lifetime
- 1990-01-30 HU HU90592A patent/HU209290B/hu not_active IP Right Cessation
- 1990-01-30 FI FI900464A patent/FI900464A7/fi not_active IP Right Cessation
- 1990-01-30 PT PT93009A patent/PT93009A/pt not_active Application Discontinuation
- 1990-01-30 NO NO900432A patent/NO174887C/no unknown
- 1990-01-30 KR KR1019900000994A patent/KR0139288B1/ko not_active Expired - Fee Related
- 1990-01-30 DE DE69025967T patent/DE69025967T2/de not_active Expired - Fee Related
- 1990-01-30 ES ES90101809T patent/ES2087093T3/es not_active Expired - Lifetime
- 1990-01-31 CN CN90100431A patent/CN1022754C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1044653A (zh) | 1990-08-15 |
| JPH02247165A (ja) | 1990-10-02 |
| NO174887B (no) | 1994-04-18 |
| AU629290B2 (en) | 1992-10-01 |
| NO174887C (no) | 1994-07-27 |
| FI900464A0 (fi) | 1990-01-30 |
| EP0381141B1 (en) | 1996-03-20 |
| HU209290B (en) | 1994-04-28 |
| PT93009A (pt) | 1990-07-31 |
| IL93187A0 (en) | 1990-11-05 |
| CN1022754C (zh) | 1993-11-17 |
| ATE135702T1 (de) | 1996-04-15 |
| AR245694A1 (es) | 1994-02-28 |
| NO900432L (no) | 1990-08-01 |
| JP2841305B2 (ja) | 1998-12-24 |
| EP0381141A2 (en) | 1990-08-08 |
| FI900464A7 (fi) | 1990-08-01 |
| KR0139288B1 (ko) | 1998-05-15 |
| DE69025967T2 (de) | 1996-08-29 |
| NO900432D0 (no) | 1990-01-30 |
| HU900592D0 (en) | 1990-04-28 |
| CA2008616C (en) | 2000-07-18 |
| EP0381141A3 (en) | 1991-11-21 |
| IL93187A (en) | 1994-12-29 |
| ZA90554B (en) | 1990-10-31 |
| DE69025967D1 (de) | 1996-04-25 |
| AU4875990A (en) | 1990-08-09 |
| KR900011725A (ko) | 1990-08-02 |
| HUT53868A (en) | 1990-12-28 |
| CA2008616A1 (en) | 1990-07-31 |
| ES2087093T3 (es) | 1996-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60225316T2 (de) | Cyanoalkylamino-derivate als protease-hemmer | |
| KR960009570B1 (ko) | 이미다졸린 유도체 및 그의 제조방법 | |
| US5041554A (en) | Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions | |
| JPH01301661A (ja) | 新規ピリジル誘導体 | |
| FR2700472A1 (fr) | Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2. | |
| CA2008616C (en) | Aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions | |
| KR900006118B1 (ko) | 4-퀴놀론 유도체의 제법 | |
| JPWO2019031471A1 (ja) | 脂肪性肝疾患の治療剤及び肥満症の治療剤 | |
| US5039695A (en) | Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions | |
| DE60107055T2 (de) | Thienopyridinderivate zur verwendung als entzündungshemmende mittel | |
| AU625688B2 (en) | Method of using aryl- or heteroaryl-1-alkyl-pyrrole-2- carboxylic acid compounds in the treatment of interleukin-1 mediated conditions | |
| US20090270494A1 (en) | Salts of Dihydroxyanthraquinone Carboxylic Acids and Their Therapeutic Use | |
| US5026861A (en) | Substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-ones | |
| MXPA03005884A (es) | Hemimaleato de amlodipina. | |
| KR0171190B1 (ko) | 신규 아스코르브산 유도체 | |
| CA2313302C (fr) | Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EP2917204A1 (fr) | Derives de 1 h-indole-3-carboxamide et leurs utilisation comme antagonistes du p2y12 | |
| JPH05301865A (ja) | 新規テトラヒドロフラン誘導体及びテトラヒドロチオフェン誘導体 | |
| FR2573761A1 (fr) | Acylamino hydroxyalcanoyl amino et imino acides et esters a action therapeutique | |
| US5109010A (en) | Dibenzofuranyl substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-ones | |
| EP0410379A2 (en) | Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins | |
| JP2000290280A (ja) | フェニルアゾール化合物、製造法及び抗高脂血症薬 | |
| DE19624290A1 (de) | Verwendungen von Pyrrolizin-Verbindungen in der Pharmazie | |
| JPS60202820A (ja) | 抗脂血剤 | |
| PT100774A (pt) | "3-(tetrazolil substituidos)4-oxo-4h-pirido-{1,2-a}-pirimidinas, seus sais, composicoes farmaceuticas que as contem e processos para a sua preparacao" |